{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:02:13Z","timestamp":1783350133987,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K10825"],"award-info":[{"award-number":["17K10825"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12975-018-0650-y","type":"journal-article","created":{"date-parts":[[2018,7,22]],"date-time":"2018-07-22T23:28:26Z","timestamp":1532302106000},"page":"381-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Dose-Dependent Inhibitory Effects of Cilostazol on Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8555-5448","authenticated-orcid":false,"given":"Hidenori","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yume","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hakozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"650_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0140-6736(16)30668-7","volume":"389","author":"RL Macdonald","year":"2017","unstructured":"Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389:655\u201366.","journal-title":"Lancet"},{"key":"650_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12975-014-0380-8","volume":"6","author":"H Suzuki","year":"2015","unstructured":"Suzuki H. What is early brain injury? Transl Stroke Res. 2015;6:1\u20133.","journal-title":"Transl Stroke Res"},{"key":"650_CR3","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MDI Vergouwen","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391\u20135.","journal-title":"Stroke"},{"key":"650_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12975-016-0500-8","volume":"8","author":"H Suzuki","year":"2017","unstructured":"Suzuki H, Shiba M, Nakatsuka Y, Nakano F, Nishikawa H. Higher cerebrospinal fluid pH may contribute to the development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Transl Stroke Res. 2017;8:165\u201373.","journal-title":"Transl Stroke Res"},{"key":"650_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4103\/1673-5374.177721","volume":"11","author":"H Suzuki","year":"2016","unstructured":"Suzuki H, Kawakita F. Tenascin-C in aneurysmal subarachnoid hemorrhage: deleterious or protective? Neural Regen Res. 2016;11:230\u20131.","journal-title":"Neural Regen Res"},{"key":"650_CR6","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3171\/2015.4.JNS15484","volume":"124","author":"M Fujimoto","year":"2016","unstructured":"Fujimoto M, Shiba M, Kawakita F, Liu L, Shimojo N, Imanaka-Yoshida K, et al. Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice. J Neurosurg. 2016;124:1693\u2013702.","journal-title":"J Neurosurg"},{"key":"650_CR7","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1007\/s12035-015-9386-9","volume":"53","author":"L Liu","year":"2016","unstructured":"Liu L, Fujimoto M, Kawakita F, Nakano F, Imanaka-Yoshida K, Yoshida T, et al. Anti-vascular endothelial growth factor treatment suppresses early brain injury after subarachnoid hemorrhage in mice. Mol Neurobiol. 2016;53:4529\u201338.","journal-title":"Mol Neurobiol"},{"key":"650_CR8","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1161\/STROKEAHA.117.016629","volume":"48","author":"L Liu","year":"2017","unstructured":"Liu L, Kawakita F, Fujimoto M, Nakano F, Imanaka-Yoshida K, Yoshida T, et al. Role of periostin in early brain injury after subarachnoid hemorrhage in mice. Stroke. 2017;48:1108\u201311.","journal-title":"Stroke"},{"key":"650_CR9","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s12035-017-0466-x","volume":"55","author":"M Fujimoto","year":"2017","unstructured":"Fujimoto M, Shiba M, Kawakita F, Liu L, Shimojo N, Imanaka-Yoshida K, et al. Effects of tenascin-C knockout on cerebral vasospasm after experimental subarachnoid hemorrhage in mice. Mol Neurobiol. 2017;55:1951\u20138. https:\/\/doi.org\/10.1007\/s12035-017-0466-x .","journal-title":"Mol Neurobiol"},{"key":"650_CR10","doi-asserted-by":"publisher","unstructured":"Liu L, Fujimoto M, Nakano F, Nishikawa H, Okada T, Kawakita F, et al. Deficiency of tenascin-C alleviates neuronal apoptosis and neuroinflammation after experimental subarachnoid hemorrhage in mice. Mol Neurobiol. 2018; https:\/\/doi.org\/10.1007\/s12035-018-1006-z .","DOI":"10.1007\/s12035-018-1006-z"},{"key":"650_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1179\/174313208X355495","volume":"32","author":"H Suzuki","year":"2010","unstructured":"Suzuki H, Kanamaru K, Suzuki Y, Aimi Y, Matsubara N, Araki T, et al. Tenascin-C is induced in cerebral vasospasm after subarachnoid hemorrhage in rats and humans: a pilot study. Neurol Res. 2010;32:179\u201384.","journal-title":"Neurol Res"},{"key":"650_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jtcvs.2003.11.015","volume":"128","author":"K Fujinaga","year":"2004","unstructured":"Fujinaga K, Onoda K, Yamamoto K, Imanaka-Yoshida K, Takao M, Shimano T, et al. Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell proliferation in free artery grafts. J Thorac Cardiovasc Surg. 2004;128:357\u201363.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"650_CR13","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1179\/016164109X12608733393791","volume":"32","author":"A Nishino","year":"2010","unstructured":"Nishino A, Umegaki M, Fujinaka T, Yoshimine T. Cilostazol attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Neurol Res. 2010;32:873\u20138.","journal-title":"Neurol Res"},{"key":"650_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.nbd.2008.07.004","volume":"32","author":"H Ito","year":"2008","unstructured":"Ito H, Fukunaga M, Suzuki H, Miyakoda G, Ishikawa M, Yabuuchi Y, et al. Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: evaluation using black blood magnetic resonance imaging. Neurobiol Dis. 2008;32:157\u201361.","journal-title":"Neurobiol Dis"},{"key":"650_CR15","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1007\/s00330-016-4702-y","volume":"27","author":"G Boulouis","year":"2017","unstructured":"Boulouis G, Labeyrie MA, Raymond J, Rodriguez-R\u00e9gent C, Lukaszewicz AC, Bresson D, et al. Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Eur Radiol. 2017;27:3333\u201342.","journal-title":"Eur Radiol"},{"key":"650_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.9.JNS12492","volume":"118","author":"N Senbokuya","year":"2013","unstructured":"Senbokuya N, Kinouchi H, Kanemaru K, Ohashi Y, Fukamachi A, Yagi S, et al. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg. 2013;118:121\u201330.","journal-title":"J Neurosurg"},{"key":"650_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000445509","volume":"42","author":"N Matsuda","year":"2016","unstructured":"Matsuda N, Naraoka M, Ohkuma H, Shimamura N, Ito K, Asano K, et al. Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial. Cerebrovasc Dis. 2016;42:97\u2013105.","journal-title":"Cerebrovasc Dis"},{"key":"650_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000327040","volume":"32","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Sayama T, Nakamura T, Nishimura H, Ohta M, Inoue T, et al. Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report. Cerebrovasc Dis. 2011;32:89\u201393.","journal-title":"Cerebrovasc Dis"},{"key":"650_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3171\/2016.8.JNS161075","volume":"128","author":"J Konczalla","year":"2018","unstructured":"Konczalla J, Seifert V, Beck J, G\u00fcresir E, Vatter H, Raabe A, et al. Outcome after Hunt and Hess grade V subarachnoid hemorrhage: a comparison of pre-coiling era (1980-1995) versus post-ISAT era (2005-2014). J Neurosurg. 2018;128:100\u201310.","journal-title":"J Neurosurg"},{"key":"650_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.5551\/jat.4309","volume":"17","author":"AR Yoo","year":"2010","unstructured":"Yoo AR, Koh SH, Cho GW, Kim SH. Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1\/2 pathway. J Atheroscler Thromb. 2010;17:1009\u201318.","journal-title":"J Atheroscler Thromb"},{"issue":"7A","key":"650_CR21","first-page":"1173","volume":"35","author":"T Niki","year":"1985","unstructured":"Niki T, Mori H. Phase I study of cilostazol: safety evaluation at increasing single doses in healthy volunteers. Arzneimittelforschung. 1985;35(7A):1173\u201385.","journal-title":"Arzneimittelforschung"},{"key":"650_CR22","first-page":"985","volume":"68","author":"CG Drake","year":"1988","unstructured":"Drake CG. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale [letter]. J Neurosurg. 1988;68:985\u20136.","journal-title":"J Neurosurg"},{"key":"650_CR23","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s00415-006-0184-1","volume":"253","author":"H Suzuki","year":"2006","unstructured":"Suzuki H, Muramatsu M, Tanaka K, Fujiwara H, Kojima T, Taki W. Cerebrospinal fluid ferritin in chronic hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurol. 2006;253:1170\u20136.","journal-title":"J Neurol"},{"key":"650_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"650_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150\u201361.","journal-title":"Pharm Stat"},{"key":"650_CR26","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083\u2013107.","journal-title":"Stat Med"},{"key":"650_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1227\/01.NEU.0000218821.34014.1B","volume":"59","author":"JA Frontera","year":"2006","unstructured":"Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21\u20137.","journal-title":"Neurosurgery"},{"key":"650_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000223439","volume":"28","author":"M Yamaguchi-Okada","year":"2009","unstructured":"Yamaguchi-Okada M, Nishizawa S, Mizutani A, Namba H. Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model. Cerebrovasc Dis. 2009;28:135\u201342.","journal-title":"Cerebrovasc Dis"},{"key":"650_CR29","first-page":"421","volume":"17","author":"H Uchida","year":"1985","unstructured":"Uchida H, Mishima Y, Tanabe T, Furukawa K, Ohashi S, Sakaguchi S, et al. Therapeutic effect of OPC-13013 on chronic arterial occlusive diseases. Cardioangiology. 1985;17:421\u201332.","journal-title":"Cardioangiology"},{"key":"650_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3171\/2016.5.JNS152907","volume":"127","author":"Y Nakatsuka","year":"2017","unstructured":"Nakatsuka Y, Kawakita F, Yasuda R, Umeda Y, Toma N, Sakaida H, et al. Preventive effects of cilostazol against the development of shunt-dependent hydrocephalus after subarachnoid hemorrhage. J Neurosurg. 2017;127:319\u201326.","journal-title":"J Neurosurg"},{"key":"650_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/neuros\/nyx364","volume":"83","author":"SH Ahn","year":"2017","unstructured":"Ahn SH, Savarraj JP, Pervez M, Jones W, Park J, Jeon SB, et al. The subarachnoid hemorrhage early brain edema score predicts delayed cerebral ischemia and clinical outcomes. Neurosurgery. 2017;83:137\u201345. https:\/\/doi.org\/10.1093\/neuros\/nyx364 .","journal-title":"Neurosurgery"},{"key":"650_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12975-013-0257-2","volume":"4","author":"M Fujii","year":"2013","unstructured":"Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res. 2013;4:432\u201346.","journal-title":"Transl Stroke Res"},{"key":"650_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/ANA.0b013e31822aa1f2","volume":"23","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Kanamaru K, Shiba M, Fujimoto M, Imanaka-Yoshida K, Yoshida T, et al. Cerebrospinal fluid tenascin-C in cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2011;23:310\u20137.","journal-title":"J Neurosurg Anesthesiol"},{"key":"650_CR34","doi-asserted-by":"crossref","unstructured":"Suzuki H, Nishikawa H, Kawakita F. Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage. Neural Regen Res. 2018;13:1175\u20138.","DOI":"10.4103\/1673-5374.235022"},{"key":"650_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4103\/1673-5374.200795","volume":"12","author":"T Okada","year":"2017","unstructured":"Okada T, Suzuki H. Toll-like receptor 4 as a possible therapeutic target for delayed brain injuries after aneurysmal subarachnoid hemorrhage. Neural Regen Res. 2017;12:193\u20136.","journal-title":"Neural Regen Res"},{"key":"650_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.wneu.2017.07.114","volume":"107","author":"F Al-Mufti","year":"2017","unstructured":"Al-Mufti F, Amuluru K, Smith B, Damodara N, El-Ghanem M, Singh IP, et al. Emerging markers of early brain injury and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. World Neurosurg. 2017;107:148\u201359.","journal-title":"World Neurosurg"},{"key":"650_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cca.2017.10.009","volume":"475","author":"YK Zheng","year":"2017","unstructured":"Zheng YK, Dong XQ, Du Q, Wang H, Yang DB, Zhu Q, et al. Comparison of plasma copeptin and multiple biomarkers for assessing prognosis of patients with aneurysmal subarachnoid hemorrhage. Clin Chim Acta. 2017;475:64\u20139.","journal-title":"Clin Chim Acta"},{"key":"650_CR38","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2174\/1570161112666140613115813","volume":"12","author":"S Satoh","year":"2014","unstructured":"Satoh S, Ikegaki I, Kawasaki K, Asano T, Shibuya M. Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: a review of preclinical and clinical studies. Curr Vasc Pharmacol. 2014;12:758\u201365.","journal-title":"Curr Vasc Pharmacol"},{"key":"650_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/01.RES.0000246172.77441.f1","volume":"99","author":"R Chapados","year":"2006","unstructured":"Chapados R, Abe K, Ihida-Stansbury K, McKean D, Gates AT, Kern M, et al. ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling. Circ Res. 2006;99:837\u201344.","journal-title":"Circ Res"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-018-0650-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-018-0650-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-018-0650-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T14:15:22Z","timestamp":1720448122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-018-0650-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1007\/s12975-018-0650-y","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"15 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study as to TNC measurements. For other retrospective analyses, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}